Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Line Broch

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Neurology|October 22, 2020
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progressionCecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Frontiers in Neurology|July 5, 2021
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based RegistryCecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2025
Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort studyCecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Multiple Sclerosis and Related Disorders|March 31, 2022
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohortHeidi Øyen Flemmen, Cecilia Smith Simonsen, Line Broch, et al.
Multiple Sclerosis and Related Disorders|June 10, 2021
Maternal education has significant influence on progression in multiple sclerosisHeidi Øyen Flemmen, Cecilia Smith Simonsen, Line Broch, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Neurology|October 22, 2020
The course of multiple sclerosis rewritten: a Norwegian population-based study on disease demographics and progressionCecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Frontiers in Neurology|July 5, 2021
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based RegistryCecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 17, 2025
Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort studyCecilia Smith Simonsen, Heidi Øyen Flemmen, Line Broch, et al.
Multiple Sclerosis and Related Disorders|March 31, 2022
The influence of socioeconomic factors on access to disease modifying treatment in a Norwegian multiple sclerosis cohortHeidi Øyen Flemmen, Cecilia Smith Simonsen, Line Broch, et al.
Multiple Sclerosis and Related Disorders|June 10, 2021
Maternal education has significant influence on progression in multiple sclerosisHeidi Øyen Flemmen, Cecilia Smith Simonsen, Line Broch, et al.
Pageof 2